FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

35171811000001100: Midotense 2.5mg tablets (Transdermal Ltd) 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 21-Mar 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
106450901000001110 Midotense 2.5mg tablets (Transdermal Ltd) 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
106451001000001118 Midotense 2.5mg tablets (Transdermal Ltd) 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Midotense 2.5mg tablets (Transdermal Ltd) 30 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Midotense 2.5mg tablets (Transdermal Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Midotense 2.5mg tablets (Transdermal Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Midotense 2.5mg tablets (Transdermal Ltd) 30 tablet Is a Midodrine 2.5mg tablets 30 tablet true Inferred relationship Existential restriction modifier
Midotense 2.5mg tablets (Transdermal Ltd) 30 tablet Has AMP Midotense 2.5mg tablets (Transdermal Ltd) true Inferred relationship Existential restriction modifier
Midotense 2.5mg tablets (Transdermal Ltd) 30 tablet Has basis of strength substance Midodrine hydrochloride true Inferred relationship Existential restriction modifier 1
Midotense 2.5mg tablets (Transdermal Ltd) 30 tablet Has presentation strength numerator value 2.5 false Inferred relationship Existential restriction modifier 1
Midotense 2.5mg tablets (Transdermal Ltd) 30 tablet Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 1
Midotense 2.5mg tablets (Transdermal Ltd) 30 tablet Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Midotense 2.5mg tablets (Transdermal Ltd) 30 tablet Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 1
Midotense 2.5mg tablets (Transdermal Ltd) 30 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Midotense 2.5mg tablets (Transdermal Ltd) 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Midotense 2.5mg tablets (Transdermal Ltd) 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Midotense 2.5mg tablets (Transdermal Ltd) 30 tablet Has specific active ingredient Midodrine hydrochloride true Inferred relationship Existential restriction modifier
Midotense 2.5mg tablets (Transdermal Ltd) 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Midotense 2.5mg tablets (Transdermal Ltd) 30 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Midotense 2.5mg tablets (Transdermal Ltd) 30 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Midotense 2.5mg tablets (Transdermal Ltd) 30 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start